The panel formulated and provided the rationale for recommendations in favor of or against treatment interventions for idiopathic pulmonary fibrosis.

No abstract

No abstract

No abstract

No abstract

It is desirable for systematic review authors, guideline panelists, and health technology assessors to specify the threshold or ranges they are using when rating the certainty in evidence.

No abstract

Expanding the use of patient portals will require an understanding of obstacles that prevent access for those who might benefit most from this technology.